-
Scrianen -CPHI Frankfurt 2025
Beijing Scrianen Pharmaceutical Co., Ltd. is pleased to announce the successful completion of its participation in CPHI Frankfurt 2025, one of the world’s leading pharmaceutical exhibitions held at the Messe Frankfurt Exhibition Centre, Germany.
넶1 2025-11-01 -
Polydeoxyribonucleotide PDRN
Polydeoxyribonucleotide (PDRN) is a biologically active compound derived from purified fragments of DNA, typically obtained from salmon sperm. It is a polymer of deoxyribonucleotides with an average molecular weight between 50–1500 kDa.
넶11 2025-09-12 -
Methotrexate API
Methotrexate API refers to the Active Pharmaceutical Ingredient form of methotrexate — the pure chemical substance used to manufacture methotrexate-containing medicines.
넶10 2025-08-14 -
Promestriene Active Pharmaceutical Ingredient
Promestriene, a synthetic estrogen, is commonly used in topical formulations for treating various conditions associated with estrogen deficiency, particularly in the urogenital tract. Below is a detailed description of Promestriene's Active Pharmaceutical Ingredient (API) characteristics:
넶37 2025-06-06 -
Acetazolamide API (Active Pharmaceutical Ingredient)
Acetazolamide API (Active Pharmaceutical Ingredient)
넶70 2025-04-25
